Rhythm Pharmaceuticals

+$0.22 (+1.75%) Today

-$0.12 (-0.94%) As of 12:47 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.

CEO

David P. Meeker

Employees

Headquarters

Boston, Massachusetts

Founded

2008

RYTM Key Statistics

Market Cap

642.91M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

205.10K

High Today

$12.80

Low Today

$12.22

Open Price

$12.59

Volume

95.32K

52 Week High

$43.26

52 Week Low

$11.53

Analyst Ratings

57%

of 7 ratings

Buy

57.1%

Hold

14.3%

Sell

28.6%

RYTM Earnings

-$0.89

-$0.59

-$0.30

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 1, Pre-Market